Published in Thromb Haemost on November 01, 2006
Platelet activation in patients with atherosclerotic renal artery stenosis undergoing stent revascularization. Clin J Am Soc Nephrol (2011) 0.79
Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med (2013) 5.19
Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study. Mayo Clin Proc (2005) 2.17
Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease. J Vasc Surg (2007) 2.06
Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc (2008) 1.97
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2011) 1.81
Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival. Thromb Haemost (2006) 1.76
The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation (2012) 1.75
Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. Circulation (2010) 1.56
Factors contributing to individual propensity for arterial thrombosis. Arterioscler Thromb Vasc Biol (2002) 1.42
Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis. Thromb Haemost (2008) 1.39
Dabigatran: a primer for neurosurgeons. World Neurosurg (2012) 1.39
Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease). J Am Coll Cardiol (2004) 1.22
In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J Appl Physiol (1985) (2006) 1.13
Clinical characteristics and long-term follow-up of patients with renal vein thrombosis. Am J Kidney Dis (2008) 1.07
Acute venous disease: venous thrombosis and venous trauma. J Vasc Surg (2007) 1.06
Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol (2009) 1.04
Adrenal haemorrhage due to heparin-induced thrombocytopenia. Thromb Haemost (2013) 0.98
Predicting left atrial thrombi in atrial fibrillation. Am Heart J (2010) 0.94
Surgical pathology of hypothenar hammer syndrome with new pathogenetic insights: A 25-year institutional experience with clinical and pathologic review of 67 cases. Am J Surg Pathol (2013) 0.92
Brain lesions in cerebral venous sinus thrombosis. Stroke (2009) 0.92
Periprocedural bridging management of anticoagulation. Circulation (2012) 0.90
Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia. J Am Coll Cardiol (2013) 0.89
Stapled aortic anastomoses: a minimally invasive, feasible alternative to videoscopic aortic suturing? Vasc Endovascular Surg (2004) 0.88
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. Thromb Haemost (2014) 0.87
Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients. Thromb Res (2009) 0.87
Platelet characteristics change with aging: role of estrogen receptor beta. J Gerontol A Biol Sci Med Sci (2005) 0.87
Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy. Arterioscler Thromb Vasc Biol (2009) 0.84
Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation. Arterioscler Thromb Vasc Biol (2011) 0.82
Cardiomyopathy associated with celiac disease. Mayo Clin Proc (2005) 0.82
The impact of peripheral arterial disease on circulating platelets. Thromb Res (2004) 0.81
Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series. Anesth Analg (2003) 0.81
The association of active cancer with venous thromboembolism location: a population-based study. Mayo Clin Proc (2011) 0.81
Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigs. Arterioscler Thromb Vasc Biol (2007) 0.81
Antithrombotic therapy and invasive procedures. N Engl J Med (2013) 0.79
Outcomes of venoplasty with stent placement for chronic thrombosis of the iliac and femoral veins: single-center experience. J Vasc Interv Radiol (2012) 0.79
The role of novel anticoagulants in the management of venous thromboembolic disease. Curr Treat Options Cardiovasc Med (2014) 0.79
Lupus anticoagulant, warfarin, and alternative laboratory monitoring of anticoagulation. J Thromb Thrombolysis (2014) 0.79
Physical and enzymatic perturbation of the architecture of the Tunica media destroys its inherent thromboresistance. Thromb Haemost (2002) 0.79
Budd-Chiari syndrome, mediastinal mass and recalcitrant leg ulcers, an unlikely trio. J Thromb Thrombolysis (2010) 0.79
Platelet recruitment to venous stent thrombi. J Thromb Thrombolysis (2013) 0.78
Platelet activation and its patient-specific consequences. Thromb Res (2007) 0.78
Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients. Am J Transplant (2005) 0.78
Individual propensity for thrombosis: comparison of venous and arterial circulations. Thromb Res (2007) 0.78
Influence of anatomical location on arterial thrombosis. Arterioscler Thromb Vasc Biol (2002) 0.78
Reasons for the persistent incidence of venous thromboembolism. Thromb Haemost (2016) 0.77
Fibrin d-dimer concentration, deep vein thrombosis symptom duration, and venous thrombus volume. Angiology (2010) 0.77
Platelet factor XIII gene expression and embolic propensity in atrial fibrillation. Thromb Haemost (2011) 0.77
Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thromb Haemost (2003) 0.77
Reduced high shear platelet adhesion to the vascular media: defective von Willebrand factor binding to the interstitial collagen. Thromb Haemost (2002) 0.76
Correlation of point-of-care International Normalized Ratio to laboratory International Normalized Ratio in hemodialysis patients taking warfarin. Clin J Am Soc Nephrol (2008) 0.75
A new platelet preservative. Platelets (2002) 0.75
Clinical pearls in vascular medicine and anticoagulation. Dis Mon (2015) 0.75
Images in vascular medicine. Fibromuscular dysplasia: an atypical cause of intermittent claudication. Vasc Med (2004) 0.75
Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation. Expert Rev Cardiovasc Ther (2014) 0.75
Portal venous thrombosis after distal pancreatectomy: clinical outcomes. J Gastrointest Surg (2014) 0.75
Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers. Am J Clin Pathol (2008) 0.75
Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation. J Am Coll Cardiol (2016) 0.75
Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart valve patients. Int J Cardiol (2013) 0.75
Images in vascular medicine. Popliteal venous aneurysm. Vasc Med (2009) 0.75
Thrombophilia differences in splanchnic vein thrombosis and lower extremity deep venous thrombosis in North America. J Gastroenterol (2012) 0.75
Health-related quality of life in children and young adults with post-thrombotic syndrome: results from a cross-sectional study. Pediatr Blood Cancer (2014) 0.75
Septic venous thromboembolism. Vasc Med (2012) 0.75
Development and initial validation of a questionnaire to diagnose the presence and severity of post-thrombotic syndrome in children. Pediatr Blood Cancer (2011) 0.75
Ovarian Vein Thrombosis: Incidence of Recurrent Venous Thromboembolism and Survival. Obstet Gynecol (2017) 0.75
Periprocedural anticoagulant management. Hosp Pract (1995) (2012) 0.75
Natural language processor as a tool to assess heparin induced thrombocytopenia awareness. J Thromb Thrombolysis (2012) 0.75
[Role of tissue factor in thrombotic complications]. Pol Arch Med Wewn (2004) 0.75
Arteriovenous malformation culprit or innocent bystander? J Am Coll Cardiol (2009) 0.75
Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients. J Thromb Thrombolysis (2013) 0.75